News and Comments

AGEN: IRRATIONAL REACTION AGAINST EXPECTED NEWS

  Thursday, March 20, 2014
 More...

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...

JAKAFI DEVELOPED BY INCYTE MET THE PRIMARY ENDPOINTS FOR POLYCYTHEMIA VERA

  Friday, March 07, 2014

Incyte (INCY) announced results from pivotal Phase 3 trial of Jakafi (ruxolitinib) in polycythemia vera patients who are resistant to or intolerant of hydroxyurea. The results met the primary endpoints; achieving phlebotomy independence and reducing spleen size by 35 percent or more compared to best available therapy.  More...


Recent Postings


Archive


Tags

Jazz Pharmaceuticals (JAZZ) NEKTAR (NKTR)) Bristol-Myers Squibb (BMY) REGULUS (RGLS) Ionis (IONS) Ridaforolimus Trastuzumab-DM1 Agenus (AGEN) Sequenom (SQNM) TOKAI (TKAOI) Onyx (ONXX) Inovio (INO) Intercept (ICPT) Seattle Genetics (SGEN) ARCA (ABIO) ADVENTRIX (ANX) Dendreon (DNDN) Ariad (ARIA) Auspex (ASPX) Cytokinetics (CYTK) SYNTA (SNTA) JUNO (JUNO) ACADIA (ACAD) Dynavax (DVAX) Alnylam (ALNY) Incyte (INCY) HALOZYME (HALO) NANTKWEST (NK) Vertex (VRTX) INNOVIVA (INVA) PTC Therapeutics (PTCT) Elan (ELN) ABBVIE (ABBV) Prosensa (RNA) Human Genome Sciences (HGSI) Prolor Biotech (PBTH) Abbott Laboratories (ABT) OSI (OSIP) Array Pharmaceuticals (ARRY) C4 Therapeutics Agenus (AGEN Telaprevir Herceptin Roche (RHHBY) Sanofi-Aventis (SAN) GlaxoSmithKline (GSK) Zerenex Merck (MRK) Amgen (AMGN) Gilead (GILD) CompuGen (CGEN) Spike Therapeutics (ONCE) VANDA (VNDA) Valeant Pharmaceuticals International (VRX) Sarepta (SRPT) Vitae Pharmaceuticals (VTAE) Multiple Myeloma Biogen Idec (BIIB) Theravance (THRX) Illumina (ILMN) Aimmune Therapeutics (AIMT) Theravance Bio Pharma (TBPH) Ziofpharm (ZIOP) Pluristem (PSTI) ZALTRAP™ Idenix (IDIX) Tysabri KERYX (KERX) Velcade (bortezomib) Xoma (XOMA) RenenxBio (RGNX) Revlimid (lenolidamide) Galena (GALE) Roche (ROCHE) Micromet (MITI) Benlysta (belimumab) Biocryst (BCRX) Genentech NOVOCURE (NVCR) Global Cell Therapeutics (GBT) IDERA (IDRA) Anadys (ANDS) GUARDIAN HEALTH Anacor (ANAC) Endometrial Cancer Intermune (ITMN) Mirati Therapeutics (MRTX) Exelixis (EXEL) Editas (EDIT) Sangamo (SGMO) KITE (KITE) SERES THERAPEUTICS (MCRB) AERIE PHARMACEUTICALS BIOMARIN (BMRN) SUNESIS PHARMACEUTICALS (SNSS) Regeneron (REGN) Rapamune Alder Biopharmaceuticals (ALDR) Human Longevity (HLI) ImmunoGen (IMGN) Sanofi (SNY) ARGOS (ARGS) Intrexon (XON) ISIS (ISIS) AGOS (ARGS) Sanofi (SNA) galapagos (GLPG)